Eluemuno R. Blyden, PhD

home / authors / eluemuno-r-blyden-phd

Eluemuno R. Blyden, PhD, is the founder and CEO of AfriVax, Inc.

Articles

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs

Peter K. Watler, PhD;Eluemuno R. Blyden, PhD

January 2nd 2010

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: November 22nd 2024 | Updated: November 25th 2024

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: October 28th 2024 | Updated: November 25th 2024

Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development

Published: November 15th 2024 | Updated: November 25th 2024

Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs

Published: October 28th 2024 | Updated: November 25th 2024

Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.